Clinical hepatotoxicity associated with antifungal agents

@article{Kyriakidis2017ClinicalHA,
  title={Clinical hepatotoxicity associated with antifungal agents},
  author={Ioannis Kyriakidis and A. Tragiannidis and Silke Munchen and A. Groll},
  journal={Expert Opinion on Drug Safety},
  year={2017},
  volume={16},
  pages={149 - 165}
}
ABSTRACT Introduction: Invasive fungal diseases (IFDs) are a leading cause of morbidity and mortality among immunocompromised patients with bone marrow failure syndromes, hematological malignancies, hematopoietic stem cell transplantation (HSCT), those admitted in intensive care units (ICUs) and those with prolonged febrile neutropenia. IFDs occur in a setting of multiple morbidities and are associated with case fatality rates between 30 and 70%. Along with the development of classes and… Expand
56 Citations
Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
  • 23
Pre-Existing Liver Disease and Toxicity of Antifungals
  • 9
  • Highly Influenced
  • PDF
Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies
  • 20
ALSUntangled No. 50: Antifungal Therapy
  • Medicine
  • Amyotrophic lateral sclerosis & frontotemporal degeneration
  • 2019
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 160 REFERENCES
The hepatotoxicity of antifungal medications in bone marrow transplant recipients.
  • 56
  • PDF
Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis
  • 92
Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients
  • 40
  • PDF
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.
  • J. Maertens, I. Raad, +10 authors T. Walsh
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2004
  • 597
  • PDF
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).
  • A. Ullmann, M. Akova, +22 authors M. Cuenca‐Estrella
  • Medicine
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2012
  • 242
  • PDF
New and emerging treatments for fungal infections.
  • 156
  • PDF
Terbinafine-associated hepatotoxicity.
  • 56
...
1
2
3
4
5
...